1
Clinical Trials associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)随机、双盲、安慰剂对照评估十五价重组人乳头瘤病毒疫苗(汉逊酵母)在9-45周岁中国健康人群中的安全性和耐受性的Ⅰ期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and tolerability of the 15-valent recombinant human papillomavirus vaccine (Hansen yeast) in healthy Chinese people aged 9-45 years
评估十五价HPV疫苗接种于9-45周岁中国健康人群的安全性和耐受性。
[Translation] To evaluate the safety and tolerability of 15-valent HPV vaccine in healthy Chinese population aged 9-45 years.
100 Clinical Results associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
100 Translational Medicine associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
100 Patents (Medical) associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)
100 Deals associated with Recombinant 15-valent Human Papillomavirus Vaccine (Hansenula Polymorpha)(Bovax)